Recurrent Ovarian Torsion: Risk Factors and Predictors for Outcome of Oophoropexy.


Journal

Journal of minimally invasive gynecology
ISSN: 1553-4669
Titre abrégé: J Minim Invasive Gynecol
Pays: United States
ID NLM: 101235322

Informations de publication

Date de publication:
08 2022
Historique:
received: 06 02 2022
revised: 05 05 2022
accepted: 09 05 2022
pubmed: 17 5 2022
medline: 16 8 2022
entrez: 16 5 2022
Statut: ppublish

Résumé

To identify risk factors for recurrent ovarian torsion and evaluation of the efficacy of oophoropexy techniques. Case control study. Tertiary university-affiliated medical center. A total of 79 women with recurrent ovarian torsion (study group) were matched with 158 women with a single episode of ovarian torsion (control group). Laparoscopic detorsion and oophoropexy. Demographic data, clinical characteristics, ultrasound characteristics, surgical findings, surgical procedures, and torsion recurrence rates were analyzed and compared between the 2 groups between 2001 to 2020. There was an inverse association between women's age and the risk of recurrent torsion (adjusted odds ratio [aOR], 0.89; 95% confidence interval [CI], 0.83-0.96, p = .003). Moreover, in women younger than 20 years, the risk of recurrent event was substantially higher (aOR, 5.0; 95% CI, 1.56-6.15, p = .007). In addition, the absence of ovarian pathology was associated with increased risk for recurrent torsion (aOR, 14.3; 95% CI, 6.15-33.42; p <.001). Oophoropexy was performed in 46 women in the study group. The risk of recurrent torsion after oophoropexy was 30%. A long duration of pain before admission was associated with oophoropexy failure (37.5 ± 6.3 hours vs 11.7 ± 6.0 hours, p = .003). No single fixation procedure was superior to the others in terms of therapeutic success. Recurrent ovarian torsion is more common in young women with a normal-appearing ovary. Oophoropexy is a safe procedure with a risk of retorsion in 30% of the patients. We found no advantage for one fixation technique over the others.

Identifiants

pubmed: 35577246
pii: S1553-4650(22)00199-6
doi: 10.1016/j.jmig.2022.05.007
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1011-1018

Informations de copyright

Copyright © 2022 AAGL. Published by Elsevier Inc. All rights reserved.

Auteurs

Amir Akdam (A)

Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv (Drs. Akdam, Fouks, Ram, Laskov, Levin, and Cohen), Israel. Electronic address: amirakdam@gmail.com.

Nati Bor (N)

Department of Obstetrics and Gynecology, Helen Schneider Hospital for Women, Rabin Medical Center, Beilinson Hospital, Petah Tikva (Dr. Bor), Israel.

Yuval Fouks (Y)

Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv (Drs. Akdam, Fouks, Ram, Laskov, Levin, and Cohen), Israel.

Maya Ram (M)

Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv (Drs. Akdam, Fouks, Ram, Laskov, Levin, and Cohen), Israel.

Ido Laskov (I)

Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv (Drs. Akdam, Fouks, Ram, Laskov, Levin, and Cohen), Israel.

Ishai Levin (I)

Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv (Drs. Akdam, Fouks, Ram, Laskov, Levin, and Cohen), Israel.

Aviad Cohen (A)

Department of Obstetrics and Gynecology, Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, affiliated to the Sackler School of Medicine, Tel Aviv University, Tel Aviv (Drs. Akdam, Fouks, Ram, Laskov, Levin, and Cohen), Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH